Login Register Cart 0
Generic placeholder image

Current Pharmaceutical Design

Editor-in-Chief

ISSN (Print): 1381-6128
ISSN (Online): 1873-4286

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Editorial

Pharmacological Management of Resistant Hypertension in Moderate-to-advanced CKD: A Glance at Novel Non-steroidal MRAs

Author(s): Panagiotis I. Georgianos*, Vasilios Vaios, Apostolos Karligkiotis, Eleni Georgianou and Vassilios Liakopoulos

Volume 29, Issue 26, 2023

Published on: 28 August, 2023

Page: [2033 - 2035] Pages: 3

DOI: 10.2174/1381612829666230825103201

Open Access Journals Promotions 2
Next »
[1]
Noubiap JJ, Nansseu JR, Nyaga UF, Sime PS, Francis I, Bigna JJ. Global prevalence of resistant hypertension: A meta-analysis of data from 3.2 million patients. Heart 2019; 105(2): 98-105.
[http://dx.doi.org/10.1136/heartjnl-2018-313599] [PMID: 30087099]
[2]
Georgianos PI, Agarwal R. Resistant hypertension in chronic kidney disease (CKD): Prevalence, treatment particularities, and research agenda. Curr Hypertens Rep 2020; 22(10): 84.
[http://dx.doi.org/10.1007/s11906-020-01081-x] [PMID: 32880742]
[3]
De Nicola L, Gabbai FB, Agarwal R, et al. Prevalence and prognostic role of resistant hypertension in chronic kidney disease patients. J Am Coll Cardiol 2013; 61(24): 2461-7.
[http://dx.doi.org/10.1016/j.jacc.2012.12.061] [PMID: 23623908]
[4]
Williams B, Mancia G, Spiering W, et al. 2018 ESC/ESH Guidelines for the management of arterial hypertension. J Hypertens 2018; 36(10): 1953-2041.
[http://dx.doi.org/10.1097/HJH.0000000000001940] [PMID: 30234752]
[5]
Leon SJ, Whitlock R, Rigatto C, et al. Hyperkalemia-related discontinuation of renin-angiotensin-aldosterone system inhibitors and clinical outcomes in CKD: A population-based cohort study. Am J Kidney Dis 2022; 80(2): 164-173.e1.
[http://dx.doi.org/10.1053/j.ajkd.2022.01.002] [PMID: 35085685]
[6]
Trevisan M, de Deco P, Xu H, et al. Incidence, predictors and clinical management of hyperkalaemia in new users of mineralocorticoid receptor antagonists. Eur J Heart Fail 2018; 20(8): 1217-26.
[http://dx.doi.org/10.1002/ejhf.1199] [PMID: 29667759]
[7]
Agarwal R, Rossignol P, Romero A, et al. Patiromer versus placebo to enable spironolactone use in patients with resistant hypertension and chronic kidney disease (AMBER): A phase 2, randomised, double-blind, placebo-controlled trial. Lancet 2019; 394(10208): 1540-50.
[http://dx.doi.org/10.1016/S0140-6736(19)32135-X] [PMID: 31533906]
[8]
Georgianos PI, Agarwal R. Mineralocorticoid receptor antagonism in chronic kidney disease. Kidney Int Rep 2021; 6(9): 2281-91.
[http://dx.doi.org/10.1016/j.ekir.2021.05.027] [PMID: 34514191]
[9]
Bakris GL, Agarwal R, Anker SD, et al. Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes. N Engl J Med 2020; 383(23): 2219-29.
[http://dx.doi.org/10.1056/NEJMoa2025845] [PMID: 33264825]
[10]
Pitt B, Filippatos G, Agarwal R, et al. Cardiovascular events with finerenone in kidney disease and type 2 diabetes. N Engl J Med 2021; 385(24): 2252-63.
[http://dx.doi.org/10.1056/NEJMoa2110956] [PMID: 34449181]
[11]
Agarwal R, Pitt B, Palmer BF, et al. A comparative post hoc analysis of finerenone and spironolactone in resistant hypertension in moderate-to-advanced chronic kidney disease. Clin Kidney J 2023; 16(2): 293-302.
[http://dx.doi.org/10.1093/ckj/sfac234] [PMID: 36864892]
[12]
Bakris GL, Agarwal R, Chan JC, et al. Effect of finerenone on albuminuria in patients with diabetic nephropathy. JAMA 2015; 314(9): 884-94.
[http://dx.doi.org/10.1001/jama.2015.10081] [PMID: 26325557]
[13]
Agarwal R, Ruilope LM, Ruiz-Hurtado G, et al. Effect of finerenone on ambulatory blood pressure in chronic kidney disease in type 2 diabetes. J Hypertens 2023; 41(2): 295-302.
[http://dx.doi.org/10.1097/HJH.0000000000003330] [PMID: 36583355]
[14]
Bakris G, Pergola PE, Delgado B, et al. Effect of KBP-5074 on blood pressure in advanced chronic kidney disease: Results of the BLOCK-CKD study. Hypertension 2021; 78(1): 74-81.
[http://dx.doi.org/10.1161/HYPERTENSIONAHA.121.17073] [PMID: 33966452]

Rights & Permissions Print Cite
Article Metrics
33
2
Wayfinder Image
Open Access Journals Promotions
World Antimicrobial Awareness Week
© 2024 Bentham Science Publishers | Privacy Policy